chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood pressure measurement, Dizziness, Dysarthria, Dysphagia
Clinical narrative: Started feeling dizzy after vaccination; throat feeling like closing; coudnt swallow well; difficulty speaking; anxious; afraid; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (Started feeling dizzy after vaccination), OROPHARYNGEAL DISCOMFORT (throat feeling like closing), DYSPHAGIA (coudnt swallow well), DYSARTHRIA (difficulty speaking) and ANXIETY (anxious) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 025J20-2A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Anaphylaxis (Anaphylaxis to avocados). Concurrent medical conditions included Fruit allergy (Anaphylaxis to avocados).   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced DIZZINESS (Started feeling dizzy after vaccination), OROPHARYNGEAL DISCOMFORT (throat feeling like closing), DYSPHAGIA (coudnt swallow well), DYSARTHRIA (difficulty speaking), ANXIETY (anxious) and FEAR (afraid). The patient was treated with EPINEPHRINE (intramuscular) on 28-Jan-2021 at a dose of Epinephrine 0.3mg x 2 and DIPHENHYDRAMINE (intramuscular) at a dose of 50 mg. On 28-Jan-2021, DIZZINESS (Started feeling dizzy after vaccination), OROPHARYNGEAL DISCOMFORT (throat feeling like closing), DYSPHAGIA (coudnt swallow well), ANXIETY (anxious) and FEAR (afraid) had resolved. At the time of the report, DYSARTHRIA (difficulty speaking) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, Blood pressure measurement: normal (normal) BP was normal. On 28-Jan-2021, Oxygen saturation: normal (normal) spo2 normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered DIZZINESS (Started feeling dizzy after vaccination), OROPHARYNGEAL DISCOMFORT (throat feeling like closing), DYSPHAGIA (coudnt swallow well), DYSARTHRIA (difficulty speaking), ANXIETY (anxious) and FEAR (afraid) to be possibly related.    Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: No specific follow-up information recorded.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Fear, Oropharyngeal discomfort, Oxygen saturation
Clinical narrative: Started feeling dizzy after vaccination; throat feeling like closing; coudnt swallow well; difficulty speaking; anxious; afraid; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (Started feeling dizzy after vaccination), OROPHARYNGEAL DISCOMFORT (throat feeling like closing), DYSPHAGIA (coudnt swallow well), DYSARTHRIA (difficulty speaking) and ANXIETY (anxious) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 025J20-2A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Anaphylaxis (Anaphylaxis to avocados). Concurrent medical conditions included Fruit allergy (Anaphylaxis to avocados).   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced DIZZINESS (Started feeling dizzy after vaccination), OROPHARYNGEAL DISCOMFORT (throat feeling like closing), DYSPHAGIA (coudnt swallow well), DYSARTHRIA (difficulty speaking), ANXIETY (anxious) and FEAR (afraid). The patient was treated with EPINEPHRINE (intramuscular) on 28-Jan-2021 at a dose of Epinephrine 0.3mg x 2 and DIPHENHYDRAMINE (intramuscular) at a dose of 50 mg. On 28-Jan-2021, DIZZINESS (Started feeling dizzy after vaccination), OROPHARYNGEAL DISCOMFORT (throat feeling like closing), DYSPHAGIA (coudnt swallow well), ANXIETY (anxious) and FEAR (afraid) had resolved. At the time of the report, DYSARTHRIA (difficulty speaking) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, Blood pressure measurement: normal (normal) BP was normal. On 28-Jan-2021, Oxygen saturation: normal (normal) spo2 normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered DIZZINESS (Started feeling dizzy after vaccination), OROPHARYNGEAL DISCOMFORT (throat feeling like closing), DYSPHAGIA (coudnt swallow well), DYSARTHRIA (difficulty speaking), ANXIETY (anxious) and FEAR (afraid) to be possibly related.    Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: No specific follow-up information recorded.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Tenderness, Vaccination site erythema, Vaccination site rash, Vaccination site reaction
Clinical narrative: Arm got really sensitive; Arm was itchy too/it was a late arm reaction; Covid arm; Having a red arm thing in the arm where she had the shot, like a rash thing; Having a red arm thing in the arm where she had the shot, like a rash thing; This spontaneous case was reported by a patient and describes the occurrence of TENDERNESS (Arm got really sensitive), PRURITUS (Arm was itchy too/it was a late arm reaction), VACCINATION SITE REACTION (Covid arm), VACCINATION SITE RASH (Having a red arm thing in the arm where she had the shot, like a rash thing) and VACCINATION SITE ERYTHEMA (Having a red arm thing in the arm where she had the shot, like a rash thing) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O36A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure (Patient is under medication) and Cholesterol (Patient is under medication). Concomitant products included TRANDOLAPRIL and HYDROCHLOROTHIAZIDE for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TENDERNESS (Arm got really sensitive), PRURITUS (Arm was itchy too/it was a late arm reaction), VACCINATION SITE REACTION (Covid arm), VACCINATION SITE RASH (Having a red arm thing in the arm where she had the shot, like a rash thing) and VACCINATION SITE ERYTHEMA (Having a red arm thing in the arm where she had the shot, like a rash thing). At the time of the report, TENDERNESS (Arm got really sensitive), PRURITUS (Arm was itchy too/it was a late arm reaction), VACCINATION SITE REACTION (Covid arm), VACCINATION SITE RASH (Having a red arm thing in the arm where she had the shot, like a rash thing) and VACCINATION SITE ERYTHEMA (Having a red arm thing in the arm where she had the shot, like a rash thing) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications taken by the patient include blood pressure medication, cholesterol medication.  Treatment medication information is not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-058939 (E2B Linked Report). This case was linked to MOD-2021-124405 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-058939:Case for anonymous patient
Sex: F
Vaccine: COVID19
Symptoms: Gingivitis, Infection
Clinical narrative: developed infection in all body piercing; developed gingivitis; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of INFECTION (developed infection in all body piercing) and GINGIVITIS (developed gingivitis) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced INFECTION (developed infection in all body piercing) and GINGIVITIS (developed gingivitis). The patient was treated with CEPHALEXIN [CEFALEXIN] at an unspecified dose and frequency. At the time of the report, INFECTION (developed infection in all body piercing) and GINGIVITIS (developed gingivitis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drug was not reported.  Treatment drug for the event included Cephalexin antibiotics.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Myalgia
Clinical narrative: Covid like symptoms; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid like symptoms) and MYALGIA (Sore arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid like symptoms) and MYALGIA (Sore arm). At the time of the report, COVID-19 (Covid like symptoms) and MYALGIA (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reported.  No treatment medication was reported.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Hypokinesia, Neck pain, Pain in extremity
Clinical narrative: left arm started hurting; she could barely move it; the pain was up to her neck; left arm started hurting; the pain was up to her neck; she could barely move it; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of PAIN IN EXTREMITY (left arm started hurting), the second episode of PAIN IN EXTREMITY (left arm started hurting), the first episode of HYPOKINESIA (she could barely move it), the second episode of HYPOKINESIA (she could barely move it) and the first episode of NECK PAIN (the pain was up to her neck) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced the first episode of PAIN IN EXTREMITY (left arm started hurting), the first episode of HYPOKINESIA (she could barely move it) and the first episode of NECK PAIN (the pain was up to her neck). On 24-Mar-2021, the patient experienced the second episode of PAIN IN EXTREMITY (left arm started hurting), the second episode of HYPOKINESIA (she could barely move it) and the second episode of NECK PAIN (the pain was up to her neck). At the time of the report, last episode of PAIN IN EXTREMITY (left arm started hurting), the last episode of HYPOKINESIA (she could barely move it) and the last episode of NECK PAIN (the pain was up to her neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: sore arm; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and PYREXIA (slight fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and PYREXIA (slight fever). At the time of the report, PAIN IN EXTREMITY (sore arm) and PYREXIA (slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pregnancy
Clinical narrative: pregnant; This spontaneous retrospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PREGNANCY (pregnant) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A2-A and 017B2-A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 16-Sep-2021. On an unknown date, the patient experienced PREGNANCY (pregnant). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PREGNANCY (pregnant) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: rash at injection site after first dose; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE RASH (rash at injection site after first dose) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash at injection site after first dose). At the time of the report, VACCINATION SITE RASH (rash at injection site after first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-044975 (Patient Link).
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and MYALGIA (body ache and pain) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), Blood thinners and ACETAMINOPHEN for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PYREXIA (Fever) and MYALGIA (body ache and pain). At the time of the report, PYREXIA (Fever) and MYALGIA (body ache and pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications included anti-fever medication.
Age: 67.0
Sex: U
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (Runny nose). At the time of the report, RHINORRHOEA (Runny nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.   Reporter did not allow further contact
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site swelling
Clinical narrative: hot to the touch; sore; hard; 1 inch below the injection site swelled up; "fiery red"; painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch), PAIN (sore), VACCINATION SITE INDURATION (hard), VACCINATION SITE SWELLING (1 inch below the injection site swelled up) and VACCINATION SITE ERYTHEMA ("fiery red") in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch), PAIN (sore), VACCINATION SITE INDURATION (hard), VACCINATION SITE SWELLING (1 inch below the injection site swelled up), VACCINATION SITE ERYTHEMA ("fiery red") and VACCINATION SITE PAIN (painful). At the time of the report, VACCINATION SITE WARMTH (hot to the touch), PAIN (sore), VACCINATION SITE INDURATION (hard), VACCINATION SITE SWELLING (1 inch below the injection site swelled up), VACCINATION SITE ERYTHEMA ("fiery red") and VACCINATION SITE PAIN (painful) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications was not provided by the reporter. Treatment information was not provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: hot to the touch; sore; hard; 1 inch below the injection site swelled up; "fiery red"; painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch), PAIN (sore), VACCINATION SITE INDURATION (hard), VACCINATION SITE SWELLING (1 inch below the injection site swelled up) and VACCINATION SITE ERYTHEMA ("fiery red") in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch), PAIN (sore), VACCINATION SITE INDURATION (hard), VACCINATION SITE SWELLING (1 inch below the injection site swelled up), VACCINATION SITE ERYTHEMA ("fiery red") and VACCINATION SITE PAIN (painful). At the time of the report, VACCINATION SITE WARMTH (hot to the touch), PAIN (sore), VACCINATION SITE INDURATION (hard), VACCINATION SITE SWELLING (1 inch below the injection site swelled up), VACCINATION SITE ERYTHEMA ("fiery red") and VACCINATION SITE PAIN (painful) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications was not provided by the reporter. Treatment information was not provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Vaccination site warmth
Clinical narrative: Right arm is "kinda red"; Right "warmish"; Right arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Right "warmish"), PAIN IN EXTREMITY (Right arm is sore) and ERYTHEMA (Right arm is "kinda red") in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL ARTHRITIS) for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Right "warmish") and PAIN IN EXTREMITY (Right arm is sore). On 25-Mar-2021, the patient experienced ERYTHEMA (Right arm is "kinda red"). At the time of the report, VACCINATION SITE WARMTH (Right "warmish"), PAIN IN EXTREMITY (Right arm is sore) and ERYTHEMA (Right arm is "kinda red") outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient states to using a help cold compress to relieve side effects.   Most recent FOLLOW-UP information incorporated above includes: On 25-Mar-2021: Right arm is sore On 25-Mar-2021: Batch number is update, DOB is  updated
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: numbness on the left side of his face; tingling on the left side of face, around mouth, jaw and cheek, it went away and sort of came back the day of the report; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness on the left side of his face) and PARAESTHESIA (tingling on the left side of face, around mouth, jaw and cheek, it went away and sort of came back the day of the report) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included CARVEDILOL, DIAZEPAM and RABEPRAZOLE for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced HYPOAESTHESIA (numbness on the left side of his face) and PARAESTHESIA (tingling on the left side of face, around mouth, jaw and cheek, it went away and sort of came back the day of the report). At the time of the report, HYPOAESTHESIA (numbness on the left side of his face) and PARAESTHESIA (tingling on the left side of face, around mouth, jaw and cheek, it went away and sort of came back the day of the report) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypotension, Pain in extremity
Clinical narrative: low blood pressure; Pain in right leg; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPOTENSION (low blood pressure), PAIN IN EXTREMITY (Pain in right leg) and FATIGUE (Fatigue) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced HYPOTENSION (low blood pressure), PAIN IN EXTREMITY (Pain in right leg) and FATIGUE (Fatigue). At the time of the report, HYPOTENSION (low blood pressure), PAIN IN EXTREMITY (Pain in right leg) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Lymphoedema, Rash
Clinical narrative: worsening lymphedema; rash; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHOEDEMA (worsening lymphedema) and RASH (rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter. .     On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 04-Mar-2021, the patient experienced RASH (rash). On an unknown date, the patient experienced LYMPHOEDEMA (worsening lymphedema). At the time of the report, LYMPHOEDEMA (worsening lymphedema) and RASH (rash) had not resolved.            No relevant concomitant medications reported.  No treatment information was provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable   This case was linked to MOD-2021-030855 (Patient Link).
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Bed rest, Chills, Depressed mood, Fatigue, Feeling abnormal
Clinical narrative: feeling down; sore arm; cold; feeling like crap; in bed for 2 days; chills; feeling tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DEPRESSED MOOD (feeling down), PAIN (sore arm), NASOPHARYNGITIS (cold), FEELING ABNORMAL (feeling like crap) and BED REST (in bed for 2 days) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy. Concomitant products included SIMVASTATIN and RIVAROXABAN (XARELTO) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DEPRESSED MOOD (feeling down), PAIN (sore arm), NASOPHARYNGITIS (cold), FEELING ABNORMAL (feeling like crap), BED REST (in bed for 2 days), CHILLS (chills) and FATIGUE (feeling tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DEPRESSED MOOD (feeling down), PAIN (sore arm), NASOPHARYNGITIS (cold), FEELING ABNORMAL (feeling like crap), BED REST (in bed for 2 days), CHILLS (chills) and FATIGUE (feeling tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pain
Clinical narrative: feeling down; sore arm; cold; feeling like crap; in bed for 2 days; chills; feeling tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DEPRESSED MOOD (feeling down), PAIN (sore arm), NASOPHARYNGITIS (cold), FEELING ABNORMAL (feeling like crap) and BED REST (in bed for 2 days) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy. Concomitant products included SIMVASTATIN and RIVAROXABAN (XARELTO) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DEPRESSED MOOD (feeling down), PAIN (sore arm), NASOPHARYNGITIS (cold), FEELING ABNORMAL (feeling like crap), BED REST (in bed for 2 days), CHILLS (chills) and FATIGUE (feeling tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DEPRESSED MOOD (feeling down), PAIN (sore arm), NASOPHARYNGITIS (cold), FEELING ABNORMAL (feeling like crap), BED REST (in bed for 2 days), CHILLS (chills) and FATIGUE (feeling tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itching; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Alavert). Concomitant products included LORATADINE (ALAVERT) for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced PRURITUS (itching). At the time of the report, PRURITUS (itching) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Oropharyngeal pain, Stomatitis
Clinical narrative: Throat is extremely sore; Sores on her tongue; Dizziness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Throat is extremely sore), STOMATITIS (Sores on her tongue), DIZZINESS (Dizziness) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Herpes simplex (Herpes simplex outbreaks around the mouth.). Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALTREX) for Herpes simplex.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Throat is extremely sore), STOMATITIS (Sores on her tongue), DIZZINESS (Dizziness) and FATIGUE (Fatigue). At the time of the report, OROPHARYNGEAL PAIN (Throat is extremely sore), STOMATITIS (Sores on her tongue), DIZZINESS (Dizziness) and FATIGUE (Fatigue) outcome was unknown. Not Provided          No relevant concomitant medications reported.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain in extremity, Peripheral swelling
Clinical narrative: Arm has been swollen; Arm red; Arm painful when touch; Arm hard where the shot was; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm has been swollen), ERYTHEMA (Arm red), PAIN IN EXTREMITY (Arm painful when touch) and FEELING HOT (Arm hard where the shot was) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030a21a) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Cholesterol.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PERIPHERAL SWELLING (Arm has been swollen), ERYTHEMA (Arm red), PAIN IN EXTREMITY (Arm painful when touch) and FEELING HOT (Arm hard where the shot was). At the time of the report, PERIPHERAL SWELLING (Arm has been swollen), ERYTHEMA (Arm red), PAIN IN EXTREMITY (Arm painful when touch) and FEELING HOT (Arm hard where the shot was) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Blood pressure and Cholesterol meds. No treatment information provided
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Back pain, Bedridden, Headache, Malaise
Clinical narrative: Feels terrible; Weak; Headache; Backache; Aching all over; Egg size knot at injection site; In bed for three days; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feels terrible), ASTHENIA (Weak), HEADACHE (Headache), BACK PAIN (Backache) and PAIN (Aching all over) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in August 2020.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced MALAISE (Feels terrible), ASTHENIA (Weak), HEADACHE (Headache), BACK PAIN (Backache), PAIN (Aching all over), VACCINATION SITE MASS (Egg size knot at injection site) and BEDRIDDEN (In bed for three days). At the time of the report, MALAISE (Feels terrible), ASTHENIA (Weak), HEADACHE (Headache), BACK PAIN (Backache), PAIN (Aching all over), VACCINATION SITE MASS (Egg size knot at injection site) and BEDRIDDEN (In bed for three days) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: positive for covid antibodies Positive for antibodies.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medicines were reported. No treatment information reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, SARS-CoV-2 antibody test, Vaccination site mass
Clinical narrative: Feels terrible; Weak; Headache; Backache; Aching all over; Egg size knot at injection site; In bed for three days; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feels terrible), ASTHENIA (Weak), HEADACHE (Headache), BACK PAIN (Backache) and PAIN (Aching all over) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in August 2020.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced MALAISE (Feels terrible), ASTHENIA (Weak), HEADACHE (Headache), BACK PAIN (Backache), PAIN (Aching all over), VACCINATION SITE MASS (Egg size knot at injection site) and BEDRIDDEN (In bed for three days). At the time of the report, MALAISE (Feels terrible), ASTHENIA (Weak), HEADACHE (Headache), BACK PAIN (Backache), PAIN (Aching all over), VACCINATION SITE MASS (Egg size knot at injection site) and BEDRIDDEN (In bed for three days) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: positive for covid antibodies Positive for antibodies.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medicines were reported. No treatment information reported.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Swelling face
Clinical narrative: face was swollen; sore to touch rashes; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (face was swollen) and RASH (sore to touch rashes) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced SWELLING FACE (face was swollen) and RASH (sore to touch rashes). At the time of the report, SWELLING FACE (face was swollen) and RASH (sore to touch rashes) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications were reported. No treatment medications were reported.    This case was linked to MOD-2021-044534 (Patient Link).
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Oropharyngeal pain, Pain in extremity
Clinical narrative: Sore Throat; fatigued; pain in his left arm which makes it difficult to move arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in his left arm which makes it difficult to move arm), OROPHARYNGEAL PAIN (Sore Throat) and FATIGUE (fatigued) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Heart attack since an unknown date, Cancer (cancer in lymph glands) since an unknown date, Diabetes since an unknown date and Spleen operation (spleen removed in 1980's) since an unknown date. Concomitant products included WARFARIN SODIUM (COUMADIN) for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in his left arm which makes it difficult to move arm). On 24-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Sore Throat) and FATIGUE (fatigued). At the time of the report, PAIN IN EXTREMITY (pain in his left arm which makes it difficult to move arm), OROPHARYNGEAL PAIN (Sore Throat) and FATIGUE (fatigued) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       concomitant medicines: Coumadin (Heart medicine), Insulin pump, Blood pressure medicine,  Treatment medicines were not provided  Action taken with mRNA-1273 in response to the event was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: TCR follow up received.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pyrexia (fever), nausea, headache, fatigue and myalgia (muscle aches, arm soreness) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 027A21A) for an unknown indication. The patient's past medical history included COVID-19 in December 2020. On Mar 23, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 23, 2021, patient experienced pyrexia (fever), nausea, headache, fatigue and myalgia (muscle aches, arm soreness). At the time of the report, pyrexia (fever), nausea, headache, fatigue and myalgia (muscle aches, arm soreness) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Diarrhoea, Parosmia
Clinical narrative: weird smell has returned; weird smell that would come and go,Thought it was propane gas,It was a weird gross smell,Stinky,It didn't last very long when it came; Diarrhea; Scapula pain; Abdominal pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Abdominal pain), PAROSMIA (weird smell has returned), PAROSMIA (weird smell that would come and go,Thought it was propane gas,It was a weird gross smell,Stinky,It didn't last very long when it came), DIARRHOEA (Diarrhea) and ARTHRALGIA (Scapula pain) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003a21a) for COVID-19 vaccination.     The patient's past medical history included Mastectomy in 2018 and Shoulder operation (Shoulder reconstruction). Concurrent medical conditions included Breast cancer. Concomitant products included ANASTROZOLE (ANASTRAZOLE DENK) for Breast cancer, METOPROLOL, ARIPIPRAZOLE (ABILIFY), PREGABALIN (LYRICA), PARACETAMOL (TYLENOL), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), CALCIUM, VITAMIN D NOS, METHOCARBAMOL, LEVOTHYROXINE, VITAMIN D3 and MONASCUS PURPUREUS (RED YEAST RICE) for an unknown indication.   On 24-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced ABDOMINAL PAIN (Abdominal pain), DIARRHOEA (Diarrhea) and ARTHRALGIA (Scapula pain). On 07-Apr-2021, the patient experienced PAROSMIA (weird smell that would come and go,Thought it was propane gas,It was a weird gross smell,Stinky,It didn't last very long when it came). On an unknown date, the patient experienced PAROSMIA (weird smell has returned). On 02-Jun-2021, PAROSMIA (weird smell that would come and go,Thought it was propane gas,It was a weird gross smell,Stinky,It didn't last very long when it came) had resolved. At the time of the report, ABDOMINAL PAIN (Abdominal pain), DIARRHOEA (Diarrhea) and ARTHRALGIA (Scapula pain) outcome was unknown and PAROSMIA (weird smell has returned) had not resolved.            No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Follow Up Received on 10-JUN-2021 contains Updated Reporter's address and Email address, Updated Medical History, Added new concomitant medications, Added Vaccination anatomical location information, Added New event Parosmia. On 09-Aug-2021: contains new event weird smell returned.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Hyperhidrosis, Illness, Somnolence
Clinical narrative: Feeling very sick; Sweating; Couldn't get out of the bed for 4 days; Very bad joint pain; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Feeling very sick), HYPERHIDROSIS (Sweating), SOMNOLENCE (Couldn't get out of the bed for 4 days) and ARTHRALGIA (Very bad joint pain) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced ILLNESS (Feeling very sick), HYPERHIDROSIS (Sweating), SOMNOLENCE (Couldn't get out of the bed for 4 days) and ARTHRALGIA (Very bad joint pain). At the time of the report, ILLNESS (Feeling very sick) and HYPERHIDROSIS (Sweating) outcome was unknown, SOMNOLENCE (Couldn't get out of the bed for 4 days) had resolved and ARTHRALGIA (Very bad joint pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Tinnitus
Clinical narrative: tinnitus; sore arm; fatigue; This spontaneous case was reported by a nurse and describes the occurrence of TINNITUS (tinnitus), PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (tinnitus), PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue). At the time of the report, TINNITUS (tinnitus), PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue) outcome was unknown. Not Related      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-058821 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-058821:
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Headache, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Arm was sore; Headache; Body aches; Fever 99 degrees Fahrenhe; This spontaneous case was reported by an other caregiver and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), HEADACHE (Headache), MYALGIA (Body aches) and PYREXIA (Fever 99 degrees Fahrenhe) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Polio (Left leg and hip, small weakness in left arm from post polio).    On 24-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm was sore), HEADACHE (Headache), MYALGIA (Body aches) and PYREXIA (Fever 99 degrees Fahrenhe). At the time of the report, PAIN IN EXTREMITY (Arm was sore), HEADACHE (Headache), MYALGIA (Body aches) and PYREXIA (Fever 99 degrees Fahrenhe) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Body temperature: 99 (Inconclusive) 99.         Concomitant product use was not provided/unknown by the reporter.  Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the eventns; therefore, action taken with the drug in response to the events is not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Enlarged lymph node under arm; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Enlarged lymph node under arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Enlarged lymph node under arm). At the time of the report, LYMPHADENOPATHY (Enlarged lymph node under arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.